Browse Indicators

Indicator title
Percentage of ARV storage and delivery points meeting the minimum quality criteria in addition to having no stock-outs
Percent of facilities with a fully functional T&C service centre
Number of adults newly enrolled in pre-antiretroviral therapy (pre-ART) during the reporting period
Condom use during anal sex among young men who have sex with men
Distribution of feeding practices (exclusive breastfeeding, replacement feeding, mixed feeding/other) for infants born to HIV-infected women at DPT3 visit
Adult support of education on condom use for prevention of HIV/AIDS among young people
Knowledge of prevention of mother to child transmission of HIV
Number of health-care facilities providing ART services for people living with HIV with demonstrable infection control practices that include TB control
Weight gain
HIV Treatment: Survival After 12 Months on Antiretroviral Therapy
Monitoring and evaluation of collaborative TB/HIV activities
National funds spent by government on HIV/AIDS prevention programmes for young people
Number of women and men aged 15 and older who received HIV testing and counselling in the last 12 months and know their results
Capacity to provide advanced clinical and psychosocial support services for HIV/AIDS
Percentage of designated facilities providing ART in-line with national standards
Number of men reported with gonorrhoea in the past 12 months
Regulation of young people’s behaviour by a parent or primary caregiver
Estimated number of opiate users (injectors and non-injectors)
Proportion of HIV-positive TB patients who receive CPT
Number of drug regimens distributed to patients per month
Number of health facilities that offer paediatric antiretroviral therapy (ART)
HIV testing behaviour among young people
External support for chronically ill people
HIV prevalence in subpopulations of young people with high-risk behaviour
Percentage of injecting drug users with HIV still alive and known to be on treatment a) 12 months, b) 24 months and c) 60 months after initiation of antiretroviral therapy